FDA Approves First Gene Therapy for GSDIaByLuke Halpern, Associate EditorPublished: August 20th 2026 | Updated: August 21st 2026
FDA Approves Garetosmab-grts, First Treatment for FOP Bone GrowthByLuke Halpern, Associate EditorPublished: August 19th 2026 | Updated: August 20th 2026
What Real-World Data Show About Moving Patients From Humira to BiosimilarsByJustin Arzt, PharmD,Agata Siwak, PharmD, MSBA,Marnie Wickizer, PharmD, AE-C, CDCES,Ryan Schmidt, PharmD,Matt Hustad, PharmD,Robert Topp, RN, PhDJuly 24th 2026
White Bagging, Brown Bagging, and the Pharmacist Caught in the Middle ByMohammed Chammout, PharmD, BCMTMS July 2nd 2026